Loading company…
Shenzhen 01 Life Science develops microbiome-based disease research, diagnosis and treatment solutions.
Founded in 2016 and based in Shenzhen, China, Shenzhen 01 Life Science develops disease solutions based on human microbiome research. Its platform includes genetic testing, strain screening and analysis, and drug development programs for atopic dermatitis, acne, type 2 diabetes, obesity and nonalcoholic fatty liver disease. In April 2023, it raised CNY 100 million in Series B1 funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in